Clover Health Investments(CLOV) - 2024 Q1 - Quarterly Results

Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of$79.7 million Improves 2024 guidance to Insurance Revenue of $1.30 billion -$1.35 billion and Adjusted EBITDA profitability of $10 million -$30 million FRANKLIN, Tenn. – May 7, 2024 – Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" ...